A. Yildiz Et Al. , "How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study," 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , vol.25, Amsterdam, Netherlands, 2015
Yildiz, A. Et Al. 2015. How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study. 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , (Amsterdam, Netherlands).
Yildiz, A., Aydin, B., Gokmen, N., Yurt, A., Keskinoglu, P., Olson, D., ... Renshaw, P.(2015). How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study . 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Netherlands
Yildiz, A. Et Al. "How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study," 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Netherlands, 2015
Yildiz, A. Et Al. "How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study." 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , Amsterdam, Netherlands, 2015
Yildiz, A. Et Al. (2015) . "How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study." 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={A. Yildiz Et Al. }, title={How antimanic treatment via tamoxifen may affect the brain's chemistry - a double-blind placebo-controlled H-1 MRS study}, congress name={28th Congress of the European-College-of-Neuropsychopharmacology (ECNP)}, city={Amsterdam}, country={Netherlands}, year={2015}}